Executive Management Team and Board of Directors

Renzo DiCarlo

Chief Executive Officer

Renzo is a proven, results-oriented Life Sciences senior executive with over 20 years of experience. His strong customer relationship management and business development skills has delivered significant growth through product development and strategic partnerships.

Renzo has extensive international experience working in North America, Europe, Asia and Africa. He has also inspired teams to innovate and deliver first-in world NDA approved therapeutic drugs and medical devices in a variety of cultures and languages (English, French and Italian).

Anna Taylor

Executive VP of Business Development

With over 15 years of experience in the Contract Research Organization industry, Anna has held management positions in both Business Development and Project Management, assisting pharmaceutical clients world-wide with their Phase I, Bioequivalence and Bioanalytical needs.

Having been a member of the Bio Pharma team since 2007, she brings together her extensive knowledge of clinical trial research and strong acumen for client service to successfully lead Bio Pharma’s global Business Development team. Anna attended Laurentian University where she studied Nursing and Biological Science.

Janice Faulknor

Medical Director

Graduated with a Doctorate in Medicine in 1996 from the University of Ottawa, Dr. Faulknor has held senior medical roles within Pharmaceutical Contract Research Organizations, responsible for Phase 1, SAD-MAD, and Bioequivalence studies, at CRO organizations including INC Research.

She brings to BioPharma Services Inc., an extensive knowledge of CRO clinical trials, research, and clinical pharmacology. She has held roles such as Clinician/Sub-Investigator, Principal Investigator, Associate Medical Director and Medical Director with CRO organizations such as INC Research, Inflamax Research and Toronto Memory Program, along with her own Medical Practice.

Nicki Hughes

VP of Lab Operations

Nicki Hughes has a PhD in Biochemistry (1992), from the University Of London (UK). She has 20+ years’ research experience in the CRO industry, including 12+ years leading bioanalytical operations. In 2013, she founded the Bioanalytical Laboratory Services (BLS) Division of LifeLabs and built a leading bioanalytical team specializing in complex method development, method validation and the analysis of biological samples for pre-clinical and clinical drug trials (BA/BE studies).

In August 2016, Nicki and the BLS team joined BioPharma Services (BPSI) to expand Bio Pharma’s existing lab, and fortify BPSI‘s footprint in bioanalytical services, making it a global leader in full-service clinical research.

Brian Lukian

Chief Financial Officer

Brian has over 25 years of finance, strategic and business leadership. He earned his education and accreditations from Concordia University, McGill University and Ernst & Young, respectively. Brian is a member of the BPSI executive team. In his career, Brian has held various roles ranging from CFO, CEO, Managing Director and COO of $35M to 200M$ revenue businesses.

He directly contributed to the growth of many corporations including several start-ups. Brian has extensive operations and finance experience and has a proven track record at increasing company productivity. His main areas of expertise are finance strategy, acquisitions, and equity negotiations.

Wendy Rossini

VP of Finance & Privacy Officer

Graduated as a Chartered Accountant with Institute of Chartered Accountants of Ontario and worked in a number of organizations both in the manufacturing and service industry with revenues up to $40 Million.

With over 20 years of experience managing and training staff in multi locations throughout North America, Wendy also implemented controls to reduce risk of fraud, set up accounting systems and streamlined them to meet the reporting needs of the board.

Fethi Trabelsi

Chief Scientific Officer

With a PhD and post-doctoral training in Physiology-Pharmacology at the Faculty of Pharmacy at the University of Montreal, Fethi has extensive experience in early clinical phase 1-2a drug development, including studies for PK/PD bioequivalence, Phase 1 SAD/MAD integrated design, Food effect, QTc, drug-drug interaction, Study in renal-impaired patients and Biosimilar development.

He is an expert in Hybrid generic/505(b)(2) programs for EU and USA NDA submissions from initial Pre-IND meetings up until the NDA submission to the agency and also well versed in Biosimilar early clinical development study design for PK/PD evaluation.

Louis Co

VP of Clinical Strategy

Louis Co attended McMaster University and George Brown College, and is a Registered Nurse with the College of Nurses of Ontario. He has over 17 years of early and late-phase clinical research experience, working for several leading Contract Research Organizations in Canada and the United States.

Specializing in bioequivalence and bioavailability studies, Louis has overseen over 500+ clinical trials in various therapeutic areas. As the Senior Director of Clinical Operations, Louis provided leadership in day-to-day business operations, clinical trial conduct, change management and overall growth and development.

Andjica Tasic

VP of Quality Assurance

Andjica Tasic is versatile Quality Assurance Professional with over 25 years of experience working for several leading Contract Research Organizations managing clinical trials phase I, II, III and bioequivalence/bioavailability. She is a Certified Clinical Research Professional (SOCRA), graduated as Medical Laboratory Technologist and earned her certificate and accreditations from American Society of Quality (CQA).

She is an expert in establishing overall company’s Quality System and in support of the quality system, provide effective leadership support, training and guidance to all company personnel.

Dr. Esmat Dessouki

Member of the Board

Dr. Dessouki is a board certified Physician and President of ADA Medical Ltd. He is the Principal Investigator/Sub-investigator for more than 400 studies over 18 years. He has extensive experience with Neurology, Cardiology, Orthopaedics, Gastroenterology, Women’s Health, General Surgery, Endocrinology, Psychiatry, Urology, Oncology, Dermatology, Infectious, Disease, Internal Medicine, Ophthalmology, Otolaryngology and Nephrology.

Dr. Dessouki’s professional memberships include the Association of Clinical Research Professionals, The Royal College of Physicians and Surgeons of Canada, College of Physicians and Surgeons of Saskatchewan, Ontario Medical Association and Canadian Orthopaedic Association.

Dr. Magdi Gaid

Member of the Board

Dr. Magdi Gaid is a certified Anesthesiolgist who graduated from medical school at Alexandria University and his post graduate training in London, U.K. and then at the University of Toronto. Dr. Gaid is currently a consultant at the Rouge Valley Heath System in Toronto, a board member of BioPharma Services, and sub-investigator in many studies done by BioPharma Services.

Dr. Gaid was also a sub-investigator for the first study in anesthesia induction medication done in Canada. He is a member of The Canadian Medical Association, Canadian Anesthesia Society, the College of Physicians, Surgeons of Ontario Canada and the Royal College of Physicians and Surgeons of Canada.

Dr. Fathi Abuzgaya

Chairman of the Board

Dr. Abuzgaya possesses over 17 years of clinical research experience, a board certified physician and the Chief Medical Officer of Ajax Hospital. He is also the CEO and Medical Director for ADA Medical. Dr. Abuzgaya has extensive experience with Neurology, Cardiology, Orthopaedics, Gastroenterology, Women’s Health, General Surgery, Endocrinology, Psychiatry, Urology, Oncology, Dermatology, Infectious Disease, Internal Medicine, Ophthalmology, Otolaryngology and Nephrology.

His professional memberships include the Canadian Medical Association, Ontario Medical Association, the Royal College of Physicians and Surgeons of Canada, The Royal College of Physicians and the Surgeons of Ontario.